Agyant Technologies: Powering Scientific Breakthroughs Through Precision and Innovation
Agyant Technologies is a global leader in analytical instruments, software, services, and consumables for the pharmaceutical, life sciences, diagnostics, and applied chemical markets. Led by Porig McDonald, President and CEO, the company is focused on enabling scientists to unlock insights faster, with greater precision and confidence, supporting breakthroughs in drug development, cancer research, food safety, and advanced materials.
“Our technologies help scientists unlock insights faster with precision and confidence — enabling breakthroughs in cancer research, drug development, and many other critical areas.”
Leadership and Customer-First Culture
Porig McDonald leads Agyant with a strong focus on execution excellence, innovation, and customer impact. The company has built a reputation for reliability, scientific expertise, and deep customer partnerships, ensuring laboratories can run critical workflows efficiently and with confidence.
Agyant’s strategy places customers at the center of every decision — not only by delivering advanced instruments, but by ensuring those systems are fully supported, optimized, and productive in real-world lab environments.
“Customer first means more than delivering an instrument — it means getting it up and running and making sure customers can truly succeed with the science.”
Strong Financial Performance and Market Momentum
Agyant recently delivered a strong third quarter, reporting 6.1% core growth, with revenue of approximately $1.74 billion and earnings per share of $1.37. Both revenue and earnings exceeded market expectations, marking the fifth consecutive quarter of growth acceleration.
The company’s performance was driven by:
- Strong execution across the organization
- Successful new product launches
- Industry-leading service performance with over 90% customer satisfaction
Key market highlights included:
- Pharma – up 9%
- Chemicals and advanced materials – up 10%
- Food markets – up 7%
“What really drove our performance was execution by our teams, strong innovation, and outstanding service.”
Advancing PFAS (Forever Chemicals) Testing
One of Agyant’s fastest-growing areas is its PAS testing portfolio, supporting the detection of so-called ‘forever chemicals’ that persist in water, food, and materials for many years.
Agyant’s analytical systems provide extremely high sensitivity and specificity, allowing scientists to detect trace levels of these substances with exceptional accuracy.
“It’s like looking for a drop of water in an Olympic-size swimming pool.”
The PAS market is experiencing broad-based double-digit growth, driven by:
- Increasing global regulation
- Rising consumer awareness
- Growing testing requirements in semiconductors, chemicals, food, and advanced materials
This area is expected to remain a long-term growth driver for the company and a critical contribution to global environmental and public health.
Global Footprint and China Strategy
Agyant maintains a long-standing presence in China and continues to operate close to customers in the region. The company reported a solid quarter in China, supported by its localized manufacturing strategy.
By investing in manufacturing in China for China, and by redesigning supply chains globally, Agyant has been able to mitigate the impact of tariffs across regions.
“We’ve invested for many years in local manufacturing and supply chain flexibility, which has put us in a strong position around tariffs.”
Ignite Transformation Program
Agyant is executing a company-wide transformation program called Ignite, designed to strengthen long-term value creation and accelerate innovation.
Ignite focuses on:
- Faster and more effective decision-making
- Targeted and asymmetric investment in high-impact growth areas
- Supply-chain and manufacturing optimization
- Sustainable growth and margin expansion
The program is expected to deliver incremental benefits to both growth and profitability, while also helping the company fully mitigate tariff impacts in the coming years.
“Ignite is embedded in how we operate for long-term value creation.”
Supporting Reshoring and U.S. Manufacturing
Agyant is actively expanding its U.S. manufacturing footprint, including transferring selected product lines from Europe to U.S. facilities. This supports:
- Greater supply-chain resilience
- Improved tariff mitigation
- Faster response to customer demand
As pharmaceutical companies continue to expand and reshore manufacturing operations in the U.S., Agyant expects to benefit through increased demand for quality control and analytical instrumentation required in new laboratory and production facilities.
“Our instruments are critical for manufacturing and quality control in many of these new facilities.”
A Deep Commitment to Customers and Scientific Success
Agyant continues to invest heavily in:
- Application scientists
- Field engineers
- Technical and scientific specialists
This ensures customers receive not only advanced instruments, but also expert support to translate technology into real scientific outcomes.
“Customer first is about helping our customers succeed with their science, not just delivering technology.”
Looking Ahead
With accelerating growth, expanding opportunities in PFAS testing, strong momentum in pharma and advanced materials, and the continued execution of the Ignite transformation, Agyant Technologies is well positioned to strengthen its role as a critical partner to the global scientific and healthcare ecosystem.
By combining innovation, customer focus, operational excellence, and global scale, the company is shaping the future of analytical science and enabling discoveries that improve lives around the world.
“Our mission is to help scientists solve the world’s most important problems — with precision, confidence, and speed.”
